Literature DB >> 16865697

Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His.

Michael A Grassi1, John H Fingert, Todd E Scheetz, Benjamin R Roos, Robert Ritch, Sheila K West, Kazuhide Kawase, Abdirashid M Shire, Robert F Mullins, Edwin M Stone.   

Abstract

Age-related macular degeneration (AMD) is the most common cause of irreversible visual loss in the developed world. Previous studies have demonstrated that the c.1204T>C, p.Tyr402His allelic variant in the complement factor H (CFH) gene is associated with an approximately three-fold increased risk for AMD in Caucasians of predominantly European descent. Both the prevalence as well as the phenotypic spectrum of AMD varies widely among persons of different ethnicities. We hypothesized that populations with a lower prevalence of AMD might also have a lower prevalence of the CFH risk allele. In this study we sought to determine the frequency of this sequence variant in control populations of Caucasians, African Americans, Hispanics, Somalis, and Japanese. Normal control populations were assembled for each ethnic group: Caucasian (n=148), Somali (n=128), African American (n=75), Hispanic (n=81), and Japanese (n=82). Individuals were genotyped using a restriction digest assay and the frequency of the C allele at nucleotide position 1204 of the CFH gene was determined. A bioinformatic approach was used to identify SNPs in linkage disequilibrium with rs1061170 (c.1204T>C, p.Tyr402His) from the human haplotype map project database (HapMap) in order to validate the findings. We found widely discordant frequencies of the risk allele between some of the different ethnic groups: Japanese 0.07+/-0.02, Hispanics 0.17+/-0.03, African-Americans 0.35+/-0.04, Caucasians 0.34+/-0.03, and Somalis 0.34+/-0.03. Allele frequencies generated by analysis of the HapMap database were consistent with these findings. This study suggests that there are other yet unidentified genetic factors important in the pathogenesis of AMD that may mitigate the effects of c.1204T>C, p.Tyr402His variant. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865697     DOI: 10.1002/humu.20359

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  26 in total

Review 1.  Progress in defining the molecular biology of age related macular degeneration.

Authors:  Andrew Lotery; Dorothy Trump
Journal:  Hum Genet       Date:  2007-07-21       Impact factor: 4.132

2.  HTRA1 variants in exudative age-related macular degeneration and interactions with smoking and CFH.

Authors:  Pancy O S Tam; Tsz Kin Ng; David T L Liu; Wai Man Chan; Sylvia W Y Chiang; Li Jia Chen; Andrew DeWan; Josephine Hoh; Dennis S C Lam; Chi Pui Pang
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-03       Impact factor: 4.799

Review 3.  Age-related macular degeneration and the immune response: implications for therapy.

Authors:  Robert B Nussenblatt; Frederick Ferris
Journal:  Am J Ophthalmol       Date:  2007-08-15       Impact factor: 5.258

4.  Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study.

Authors:  Nicole A Restrepo; Kylee L Spencer; Robert Goodloe; Tiana A Garrett; Gerardo Heiss; Petra Bůžková; Neal Jorgensen; Richard A Jensen; Tara C Matise; Lucia A Hindorff; Barbara E K Klein; Ronald Klein; Tien Y Wong; Ching-Yu Cheng; Belinda K Cornes; E-Shyong Tai; Marylyn D Ritchie; Jonathan L Haines; Dana C Crawford
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-09       Impact factor: 4.799

5.  The prevalence and risk factors for age-related macular degeneration in rural-urban India, Sankara Nethralaya Rural-Urban Age-related Macular degeneration study, Report No. 1.

Authors:  R Raman; S S Pal; S Ganesan; L Gella; K Vaitheeswaran; T Sharma
Journal:  Eye (Lond)       Date:  2016-02-26       Impact factor: 3.775

6.  Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Frank S Ong
Journal:  Expert Rev Ophthalmol       Date:  2013-04-01

7.  Playing 'hide-and-seek' with factor H: game-theoretical analysis of a single nucleotide polymorphism.

Authors:  Sabine Hummert; Christina Glock; Stefan N Lang; Christian Hummert; Christine Skerka; Peter F Zipfel; Sebastian Germerodt; Stefan Schuster
Journal:  J R Soc Interface       Date:  2018-05       Impact factor: 4.118

Review 8.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

9.  Association of complement factor H tyrosine 402 histidine genotype with posterior involvement in sarcoid-related uveitis.

Authors:  Ian A Thompson; Baoying Liu; H Nida Sen; Xiadong Jiao; Robert Katamay; Zhiyu Li; Mengjun Hu; Fielding Hejtmancik; Robert B Nussenblatt
Journal:  Am J Ophthalmol       Date:  2013-03-14       Impact factor: 5.258

10.  Assessment of the contribution of the LOC387715 gene polymorphism in a family with exudative age-related macular degeneration and heterozygous CFH variant (Y402H).

Authors:  Barkur S Shastry
Journal:  J Hum Genet       Date:  2007-02-07       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.